MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Microbot Medical Inc

Gesloten

2.75 -2.48

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.69

Max

2.76

Belangrijke statistieken

By Trading Economics

Inkomsten

-899K

-3.5M

Winstmarge

-4,038.095

Werknemers

20

EBITDA

-84K

-3.5M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+322.54% upside

Dividenden

By Dow Jones

Volgende Winsten

12 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

31M

159M

Vorige openingsprijs

5.23

Vorige sluitingsprijs

2.75

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Microbot Medical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 okt 2025, 18:13 UTC

Belangrijke Marktbewegers

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 okt 2025, 17:05 UTC

Belangrijke Marktbewegers

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 okt 2025, 15:03 UTC

Belangrijke Marktbewegers

Obook Shares Sink Following Public Debut

17 okt 2025, 14:41 UTC

Belangrijke Marktbewegers

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 okt 2025, 23:25 UTC

Acquisities, Fusies, Overnames

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 okt 2025, 22:15 UTC

Marktinformatie

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 okt 2025, 21:15 UTC

Marktinformatie

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 okt 2025, 21:07 UTC

Marktinformatie

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 okt 2025, 21:07 UTC

Marktinformatie

Global Equities Roundup: Market Talk

17 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 okt 2025, 20:34 UTC

Marktinformatie

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 okt 2025, 20:27 UTC

Marktinformatie

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 okt 2025, 19:46 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 okt 2025, 19:45 UTC

Marktinformatie

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 okt 2025, 18:45 UTC

Marktinformatie

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 okt 2025, 17:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 okt 2025, 17:51 UTC

Marktinformatie

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 okt 2025, 17:44 UTC

Marktinformatie

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 okt 2025, 17:35 UTC

Marktinformatie

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 okt 2025, 16:20 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

17 okt 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 okt 2025, 16:14 UTC

Marktinformatie

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 okt 2025, 16:04 UTC

Marktinformatie

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 okt 2025, 15:58 UTC

Marktinformatie

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 okt 2025, 15:56 UTC

Winsten

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 okt 2025, 15:43 UTC

Marktinformatie

Global Equities Roundup: Market Talk

17 okt 2025, 15:43 UTC

Marktinformatie

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 okt 2025, 14:58 UTC

Marktinformatie

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 okt 2025, 14:41 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 okt 2025, 14:35 UTC

Marktinformatie
Winsten

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Peer Vergelijking

Prijswijziging

Microbot Medical Inc Prognose

Koersdoel

By TipRanks

322.54% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12 USD  322.54%

Hoogste 12 USD

Laagste 12 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Microbot Medical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technische score

By Trading Central

2.52 / 2.57Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat